These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26867677)

  • 1. Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation.
    Neri L; Iovino P;
    Neurogastroenterol Motil; 2016 Apr; 28(4):581-91. PubMed ID: 26867677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.
    Solem CT; Patel H; Mehta S; Mody R; Macahilig C; Gao X
    Curr Med Res Opin; 2016 May; 32(5):899-905. PubMed ID: 26836030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
    Ringel Y; Williams RE; Kalilani L; Cook SF
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC).
    Zhao YF; Ma XQ; Wang R; Yan XY; Li ZS; Zou DW; He J
    Aliment Pharmacol Ther; 2011 Oct; 34(8):1020-9. PubMed ID: 21848795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with different constipation subtypes based on the Rome III criteria.
    Ruiz-López MC; Coss-Adame E
    Rev Gastroenterol Mex; 2015; 80(1):13-20. PubMed ID: 25726441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient dissatisfaction with medical therapy for chronic constipation or irritable bowel syndrome with constipation: analysis of N-of-1 prospective trials in 81 patients.
    Basilisco G;
    Aliment Pharmacol Ther; 2020 Mar; 51(6):629-636. PubMed ID: 32048753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study.
    Bellini M; Usai-Satta P; Bove A; Bocchini R; Galeazzi F; Battaglia E; Alduini P; Buscarini E; Bassotti G;
    BMC Gastroenterol; 2017 Jan; 17(1):11. PubMed ID: 28088179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS; Baggish J; Whitehead WE
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Patients Presenting With Bloating as a Predominant Symptom.
    Said H; Nee J; Iturrino J; Rangan V; Singh P; Lembo A; Ballou S
    J Clin Gastroenterol; 2023 Sep; 57(8):830-834. PubMed ID: 36306181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal Pain Severity Is Mainly Associated with Bloating Severity in Patients with Functional Bowel Disorders and Functional Abdominal Pain.
    Deutsch D; Bouchoucha M; Uzan J; Raynaud JJ; Sabate JM; Benamouzig R
    Dig Dis Sci; 2022 Jul; 67(7):3026-3035. PubMed ID: 34324087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
    Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
    Aliment Pharmacol Ther; 2015 Mar; 41(5):449-58. PubMed ID: 25586008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
    Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.
    Lee AD; Spiegel BM; Hays RD; Melmed GY; Bolus R; Khanna D; Khanna PP; Chang L
    Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27981684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.